Original Source(s)
Related Content
EULAR Updates Behçet’s Syndrome Recommendations
EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement
April 1, 2026
-
5 min
UVB and Psoriasis: More Than Immunosuppression
UVB's benefits may run deeper than inflammation suppression—cholesterol metabolism could be a key link.
by Kerri Miller
April 6, 2026
-
3 min
IL-17, IL-23 Therapies Lead Psoriasis Care
Network meta-analysis suggests higher PASI 90 response rates with biologics vs oral systemic therapies
April 12, 2026
-
3 min